Does Favipiravir Reduce Mortality in Patients with COVID-19 ARDS and Severe Pneumonia?
Objective:Although there is no antiviral treatment specific to the virus, favipiravir has entered the treatment routine as an antiviral in our country in May 2020. In this study, in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acute respiratory distress syndrome (ARDS)...
| الحاوية / القاعدة: | Türk Yoğun Bakim Derneği Dergisi |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Turkish Society of Intensive Care
2021-12-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: |
http://www.turkishjic.org/archives/archive-detail/article-preview/does-favipiravir-reduce-mortality-in-patients-with/50667
|